Epidermal growth factor receptor (EGFR) mutation is the most frequently found oncogene driver mutation in non-small cell lung cancer (NSCLC), but its prevalence in lung squamous cell carcinoma (LSCC) is rare [1]. This evidence concerns the gene EGFR and squamous cell lung carcinoma.